Track Record

Transactions

The team has completed over 300 transactions and engagements for its clients — valued at over $35 billion — as Bookrunner, Co-Manager, Lead Placement Agent, Co-Placement Agent or Advisor.

Featured Transactions

April 2025Alcyone TherapeuticsBrookline served as Exclusive Placement Agent for the Series F Convertible Preferred stock offering.
September 2025Sale to BiogenBiogen acquired Alcyone Therapeutics in 2025. Brookline served as Alcyone's financial advisor.
July 2026Neela TherapeuticsNeela Therapeutics was spun out of the acquisition and Brookline served as the Exclusive Placement Agent for a Convertible Note in 2026.

Selected Client Transactions

NervGen Pharma
CAD $6,500,000
PIPELead US Placement Agent
August 2020
Aberdeen Standard Investments Global Infrastructure Fund
$177,000,000
IPOCo-Manager
July 2020
Genocea Biosciences
$80,000,000
PIPEFinancial Advisor
July 2020
FSD Pharma
$10,000,000
Registered DirectFinancial Advisor
July 2020
CASI Pharmaceuticals
$43,700,000
Follow-OnCo-Manager
July 2020
Atreca
$134,800,000
Follow-OnCo-Manager
July 2020
Chiasma
$80,500,000
Follow-OnCo-Manager
July 2020
Bukit Jalil Global Acquisition 1 Ltd.
$40,000,000
IPOJoint Bookrunner
July 2020
Arcturus Therapeutics
$198,900,000
Follow-OnFinancial Advisor
July 2020
First Trust High Yield Opportunities 2027 Term Fund
$665,000,000
IPOCo-Manager
June 2020
Diffusion Pharmaceuticals
Completed EngagementCapital Markets Advisor
June 2020
Aquestive Therapeutics
Completed EngagementCapital Markets Advisor
June 2020
Imunon
Completed EngagementCapital Markets Advisor
June 2020
Angel Oak Financial Strategies Income Trust
$100,000,000
IPOCo-Manager
June 2020
BioCardia
$11,500,000
Follow-OnCo-Manager
June 2020
FSD Pharma
CAD $10,100,000
PIPECo-Placement Agent
June 2020
Lisata Therapeutics
$4,300,000
Registered DirectCo-Placement Agent
May 2020
AnaBios
$1,130,000
Series C Convertible Preferred StockExclusive Placement Agent
May 2020
Arcturus Therapeutics
$80,500,000
Follow-OnFinancial Advisor
April 2020
Cyclacel Pharmaceuticals
$20,000,000
Follow-OnCo-Placement Agent
April 2020
Lisata Therapeutics
$5,000,000
Registered DirectCo-Placement Agent
April 2020
RiverNorth Managed Duration Municipal Income Fund
$110,000,000
IPOCo-Manager
March 2020
RiverNorth Managed Duration Municipal Income Fund II
$500,000,000
IPOCo-Manager
March 2020
TH Plasma
$4,000,000
Series A Convertible Preferred StockFinancial Advisor
February 2020